Package 68788-4064-3

Brand: terazosin

Generic: terazosin
NDC Package

Package Facts

Identity

Package NDC 68788-4064-3
Digits Only 6878840643
Product NDC 68788-4064
Description

30 CAPSULE in 1 BOTTLE (68788-4064-3)

Marketing

Marketing Status
Marketed Since 2026-01-28
Brand terazosin
Generic terazosin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d1718217-ddab-4a3a-a862-8c952fd5a274", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313217"], "spl_set_id": ["d1718217-ddab-4a3a-a862-8c952fd5a274"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (68788-4064-1)", "package_ndc": "68788-4064-1", "marketing_start_date": "20260128"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (68788-4064-3)", "package_ndc": "68788-4064-3", "marketing_start_date": "20260128"}], "brand_name": "Terazosin", "product_id": "68788-4064_d1718217-ddab-4a3a-a862-8c952fd5a274", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "68788-4064", "generic_name": "Terazosin", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075667", "marketing_category": "ANDA", "marketing_start_date": "20260128", "listing_expiration_date": "20271231"}